U.S. market Closed. Opens in 7 hours 51 minutes

TEVA | Teva Pharmaceutical Industries Limited Stock Overview

(Stock Exchange: NYSE)
Day's Range 18.38 - 18.80
52 Week Range 8.55 - 19.08
Beta 0.83
Implied Volatility 50.81%
IV Rank 91.30%
Day's Volume 6,725,054
Average Volume 6,590,467
Shares Outstanding 1,132,990,000
Market Cap 21,118,933,600
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 1982-02-16
Valuation
Profitability
Growth
Health
P/E Ratio -47.79
Forward P/E Ratio 3.86
EPS -0.39
1YR Price Target 9.50
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate 2017-11-27
Dividend PayDate 2017-12-12
Employees 35,001
Country Israel
Website TEVA
Teva Pharmaceutical Industries Ltd is based in Israel, together with its subsidiaries and associated companies the company is engaged in the development, manufacturing, marketing and distribution of generics, innovative medicines and biopharmaceuticals. The company operates business through three segments: North America, Europe and International Markets. Each business segment manages a product portfolio in its region, including generics, which include biosimilars and over-the-counter products, as well as innovative medicines.
TEVA's peers: BHC, ELAN, TAK, HLN, ZTS, VTRS, CTLT, MNK, SHPH, LFCR, LSDI, TLRY, CGC, ACB, SNDL, HEXO, CRON
*Chart delayed
Analyzing fundamentals for TEVA we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see TEVA Fundamentals page.

Watching at TEVA technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on TEVA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙